← SynDRA
ZANAMIVIR
SynDRA canonical compound SYN0006781 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NEU2 |
|---|
| Mechanism of action | neuraminidase inhibitor |
|---|
| Indication | influenza A virus infection |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- neuraminidase inhibitor
- Influ NA INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- HRH3
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MC4R
- MLNR
- NEU1
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC22A1
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HTR1A
- HRH2
- ADORA2A
- HRH1
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
Drug classes
- Neuraminidase Inhibitors
- Neuraminidase Inhibitor
- Anti-Infective Agents
- Antiviral Agents
- Enzyme Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- RELENZA
- Relenza
- relenza
- zanamivir hydrate
- GG-167
- GG167
- GR-121167X
- GR-121167
- 4-Guanidino-Neu5Ac2en
- GANA
- Zanamavir
- MODIFIED SIALIC ACID
- UNII-L6O3XI777I
- GR 121167X
- Zanamivir (Relenza)
- Relenza (TN)
- 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
- CHEMBL222813
- L6O3XI777I
- ZMR
- CHEBI:50663
- GANA (inhibitor)
- GNA
- AK163166
- DSSTox_CID_3749
- DSSTox_RID_77184
- DSSTox_GSID_23749
- Zanamivir [USAN:INN:BAN]
- HSDB 7437
- C12H20N4O7
- Zanamivir hydrate
- GR121167X
- Zanamivir (USAN/INN)
- 4-Guanidino-NeueAc2en
- ZNV
- BAC-zanamivir
- Zanamivir i.v.
- zanamivir (usp-rs)
Look up ZANAMIVIR in the interactive SynDRA portal →